Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37226
M Alqarni, A Abujamea, A Almudhi, S Bashir
OBJECTIVE: The neurophysiological and neuroanatomical alterations underlying brain morphology in adult males who stutter remain insufficiently understood. This study aimed to determine whether individuals who stutter exhibit structural differences in frontal brain regions associated with somatosensory and motor systems critical for speech production. MATERIALS AND METHODS: The study protocol was approved by the Institutional Review Board of King Saud University (KSU). A total of 54 adult male participants [27 stutterers (ST) and 27 non-stutterers (NST)], aged 18-55 years, were enrolled. A certified speech-language pathologist assessed all participants using the validated Stuttering Severity Instrument-4 (SSI-4). High-resolution T1-weighted magnetic resonance imaging (MRI) scans (SAG T1 3D MP-RAGE sequence) were acquired using a Siemens Skyra 3.0T scanner at the Department of Medical Imaging, KSU Medical City, Riyadh. RESULTS: Compared to NST participants, individuals in the ST group showed significant volumetric alterations in the left precentral gyrus, right superior frontal gyrus, and right middle frontal gyrus. Additional significant differences were observed in the left middle frontal gyrus, left inferior frontal gyrus pars opercularis, left inferior frontal gyrus pars triangularis, left inferior frontal gyrus, left precuneus, left pole of the superior temporal white matter, and left insular cortex. These regions demonstrated consistent structural differences between ST and NST participants, suggesting a robust association between stuttering and abnormal morphology in frontal and related cortical areas. CONCLUSIONS: These findings provide evidence of structural abnormalities in frontal brain regions implicated in the regulation of somatosensory and motor processes essential for speech production. This supports the hypothesis that stuttering is associated with disrupted neuroanatomical organization in key speech-related cortical networks.
目的:成年男性口吃患者脑形态的神经生理和神经解剖学改变尚不清楚。这项研究的目的是确定口吃的个体在与体感和运动系统相关的大脑额叶区域是否表现出结构上的差异,这些系统对语言的产生至关重要。材料和方法:研究方案由沙特国王大学(KSU)机构审查委员会批准。共纳入54名成年男性参与者[27名口吃者(ST)和27名非口吃者(NST)],年龄18-55岁。一位经过认证的语言病理学家使用经过验证的口吃严重程度量表-4 (SSI-4)对所有参与者进行评估。高分辨率T1加权磁共振成像(MRI)扫描(SAG T1 3D MP-RAGE序列)使用利雅得KSU医学城医学成像部的西门子Skyra 3.0T扫描仪。结果:与NST参与者相比,ST组的个体在左侧中央前回、右侧额上回和右侧额中回中表现出显著的体积变化。另外,在左侧额中回、左侧额下回小叶部、左侧额下回三角部、左侧额下回、左侧楔前叶、左侧颞上白质极和左侧岛叶皮层也观察到显著差异。这些区域在ST和NST参与者之间显示出一致的结构差异,表明口吃与额叶和相关皮质区域的异常形态之间存在密切联系。结论:这些发现为大脑额叶区域的结构异常提供了证据,这些结构异常与语言产生所必需的体感和运动过程的调节有关。这支持了一种假设,即口吃与关键语言相关皮层网络的神经解剖组织紊乱有关。图形摘要:https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-17.jpg。
{"title":"Brain morphology alterations in adult males with stuttering disorder in Saudi Arabia: a pilot study.","authors":"M Alqarni, A Abujamea, A Almudhi, S Bashir","doi":"10.26355/eurrev_202505_37226","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37226","url":null,"abstract":"<p><p>OBJECTIVE: The neurophysiological and neuroanatomical alterations underlying brain morphology in adult males who stutter remain insufficiently understood. This study aimed to determine whether individuals who stutter exhibit structural differences in frontal brain regions associated with somatosensory and motor systems critical for speech production. MATERIALS AND METHODS: The study protocol was approved by the Institutional Review Board of King Saud University (KSU). A total of 54 adult male participants [27 stutterers (ST) and 27 non-stutterers (NST)], aged 18-55 years, were enrolled. A certified speech-language pathologist assessed all participants using the validated Stuttering Severity Instrument-4 (SSI-4). High-resolution T1-weighted magnetic resonance imaging (MRI) scans (SAG T1 3D MP-RAGE sequence) were acquired using a Siemens Skyra 3.0T scanner at the Department of Medical Imaging, KSU Medical City, Riyadh. RESULTS: Compared to NST participants, individuals in the ST group showed significant volumetric alterations in the left precentral gyrus, right superior frontal gyrus, and right middle frontal gyrus. Additional significant differences were observed in the left middle frontal gyrus, left inferior frontal gyrus pars opercularis, left inferior frontal gyrus pars triangularis, left inferior frontal gyrus, left precuneus, left pole of the superior temporal white matter, and left insular cortex. These regions demonstrated consistent structural differences between ST and NST participants, suggesting a robust association between stuttering and abnormal morphology in frontal and related cortical areas. CONCLUSIONS: These findings provide evidence of structural abnormalities in frontal brain regions implicated in the regulation of somatosensory and motor processes essential for speech production. This supports the hypothesis that stuttering is associated with disrupted neuroanatomical organization in key speech-related cortical networks.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-17.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"278-286"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37233
Y-Q Xu, Y Xu, S-H Wang
The article "Effect of exosome-carried miR-30a on myocardial apoptosis in myocardial ischemia-reperfusion injury rats through regulating autophagy" by Y.-Q. Xu, Y. Xu, S.-H. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (16): 7066-7072-DOI: 10.26355/eurrev_201908_18748-PMID: 31486507 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised by a third party regarding possible overlaps and duplication in the Figures, the journal has started an investigation to assess the validity of the concerns, as well as a possible Figure manipulation. The journal's investigation revealed a duplication between panels Model and miR-30a inhibitor of Figure 1. Therefore, the manuscript is retracted due to figure duplication. The journal has contacted the authors to inform them of the ongoing investigation and to request the original data supporting the manuscript; however, the authors have not responded to these communications. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18748.
{"title":"Retraction note: Effect of exosome-carried miR-30a on myocardial apoptosis in myocardial ischemia-reperfusion injury rats through regulating autophagy.","authors":"Y-Q Xu, Y Xu, S-H Wang","doi":"10.26355/eurrev_202505_37233","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37233","url":null,"abstract":"<p><p>The article \"Effect of exosome-carried miR-30a on myocardial apoptosis in myocardial ischemia-reperfusion injury rats through regulating autophagy\" by Y.-Q. Xu, Y. Xu, S.-H. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (16): 7066-7072-DOI: 10.26355/eurrev_201908_18748-PMID: 31486507 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised by a third party regarding possible overlaps and duplication in the Figures, the journal has started an investigation to assess the validity of the concerns, as well as a possible Figure manipulation. The journal's investigation revealed a duplication between panels Model and miR-30a inhibitor of Figure 1. Therefore, the manuscript is retracted due to figure duplication. The journal has contacted the authors to inform them of the ongoing investigation and to request the original data supporting the manuscript; however, the authors have not responded to these communications. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18748.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"224"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37221
T Erakgün, H H Gobeka
BACKGROUND: The study aims to describe an inadvertent sub-macular triamcinolone acetonide (TA) deposition following a TA-assisted pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling. CASE REPORT: In this interventional case report, a 75-year-old female with ERM-induced visual distortion underwent TA-assisted 25-gauge three-port PPV, endolaser photocoagulation, and sulfur hexafluoride (SF6) gas (8%) endo tamponade to treat ERM in the left eye. Significant TA deposition was observed intraoperatively in the submacular region, which remained after ERM and internal limiting membrane (ILM) removal. One month after PPV, the retina appeared flat, with no significant vitreoretinal interface defects or macular ultrastructural abnormalities. Vision improved from 0.40 to 0.2 logMAR, and there was no evidence of any ophthalmoscopic damage. CONCLUSIONS: Inadvertent sub-macular TA deposition following ERM peeling did not cause any significant surgical sequelae.
{"title":"Inadvertent sub-macular triamcinolone during pars plana vitrectomy for epiretinal membrane: A case report.","authors":"T Erakgün, H H Gobeka","doi":"10.26355/eurrev_202505_37221","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37221","url":null,"abstract":"<p><p>BACKGROUND: The study aims to describe an inadvertent sub-macular triamcinolone acetonide (TA) deposition following a TA-assisted pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling. CASE REPORT: In this interventional case report, a 75-year-old female with ERM-induced visual distortion underwent TA-assisted 25-gauge three-port PPV, endolaser photocoagulation, and sulfur hexafluoride (SF6) gas (8%) endo tamponade to treat ERM in the left eye. Significant TA deposition was observed intraoperatively in the submacular region, which remained after ERM and internal limiting membrane (ILM) removal. One month after PPV, the retina appeared flat, with no significant vitreoretinal interface defects or macular ultrastructural abnormalities. Vision improved from 0.40 to 0.2 logMAR, and there was no evidence of any ophthalmoscopic damage. CONCLUSIONS: Inadvertent sub-macular TA deposition following ERM peeling did not cause any significant surgical sequelae.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-13.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"225-230"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37222
A E Abou Warda, J D Duarte, M Nabil Salem, H F Salem, A N Moharram, A S Alanazi, A I Alzarea, T G Alsahli, H Sultan, M A Alrashdi, A F Altebainawi, B Emil Ibrahim, S Ibrahim Alnahrawi, K Kamel Megalaa, B Zarif, R M Sarhan
OBJECTIVE: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have reshaped heart failure (HF) management. However, evidence regarding their effects on cardiac structure, particularly for dapagliflozin, remains inconsistent. This study evaluates dapagliflozin's impact on echocardiographic parameters and its concordance with clinical response. MATERIALS AND METHODS: A prospective, randomized controlled study included HF patients with left ventricular (LV) dysfunction, divided into dapagliflozin-treated and dapagliflozin-naïve groups. Echocardiography and speckle-tracking strain analysis were conducted at baseline and six months. The primary outcome was the change in indexed LV mass. Secondary outcomes included LV function, volumes, dimensions, functional mitral regurgitation, global longitudinal strain (GLS), diastolic function, right ventricular (RV) function, and clinical response assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ) score. RESULTS: Among 240 participants, 160 received dapagliflozin in addition to guideline-directed medical therapy, while 80 were dapagliflozin-naïve. Adjusted regression analysis showed significant improvements in LV mass index (-43.51 g/m², 95% CI: -59.4 to -27.5, p < 0.0001), end-systolic volume (-29.45 mL, 95% CI: -43.9 to -14.9, p < 0.0001), and end-diastolic volume (-29.44 mL, 95% CI: -47.9 to -10.9, p = 0.0021). Improvements were also observed in LV ejection fraction (5.15%, 95% CI: 2.84 to 7.45, p < 0.0001), GLS (-1.99%, 95% CI: -2.87 to -1.11, p < 0.0001), E/A ratio (-0.56, 95% CI: -1.01 to -0.10, p = 0.016), effective regurgitant orifice area (EROA) (-0.18 cm², 95% CI: -0.28 to -0.081, p = 0.0006), tricuspid annular plane systolic excursion (TAPSE) (0.38 cm, 95% CI: 0.15 to 0.62, p = 0.0024), and composite clinical outcome (HR 0.65, 95% CI: 0.43-0.98, p = 0.043). LVEF, GLS, E/A ratio, TAPSE, inferior vena cava diameter, and left atrial area correlated with clinical response. CONCLUSIONS: Dapagliflozin emerges as a potential therapy for patients with left ventricular dysfunction, enhancing LV systolic function and diastolic performance, alongside a favorable clinical response. Future studies with more extensive assessment of right ventricular function and longer follow-up are warranted.
目的:钠-葡萄糖共转运蛋白-2 (SGLT2)抑制剂重塑心力衰竭(HF)的管理。然而,关于它们对心脏结构的影响,特别是对达格列净的影响,证据仍然不一致。本研究评估达格列净对超声心动图参数的影响及其与临床反应的一致性。材料和方法:一项前瞻性、随机对照研究纳入了伴有左心室功能障碍的HF患者,分为达格列净组和dapagliflozin-naïve组。在基线和6个月时进行超声心动图和斑点跟踪应变分析。主要观察指标为左室指数质量的变化。次要结果包括左室功能、体积、尺寸、功能性二尖瓣反流、整体纵向应变(GLS)、舒张功能、右心室(RV)功能,以及使用堪萨斯城心肌病问卷(KCCQ)评分评估的临床反应。结果:在240名参与者中,160名在指南指导的药物治疗之外接受了达格列净,80名dapagliflozin-naïve。校正回归分析显示,左室质量指数(-43.51 g/m²,95% CI: -59.4 ~ -27.5, p < 0.0001)、收缩末期容积(-29.45 mL, 95% CI: -43.9 ~ -14.9, p < 0.0001)和舒张末期容积(-29.44 mL, 95% CI: -47.9 ~ -10.9, p = 0.0021)均有显著改善。改进也观察到在LV射血分数(5.15%,95%置信区间CI: 2.84 - 7.45, p < 0.0001), gl(-1.99%, 95%置信区间CI: -2.87 - -1.11, p < 0.0001), E / A比值(-0.56,95%置信区间CI: -1.01 - -0.10, p = 0.016),有效的二尖瓣口面积(EROA)(-0.18厘米²,95%置信区间CI: -0.28 - -0.081, p = 0.0006),三尖瓣环平面收缩偏差(TAPSE)(0.38厘米,95%置信区间CI: 0.15 - 0.62, p = 0.0024),和复合临床结果(HR 0.65, 95%置信区间CI: 0.43 - -0.98, p = 0.043)。LVEF、GLS、E/A比值、TAPSE、下腔静脉内径、左房面积与临床反应相关。结论:达格列净作为左心室功能不全患者的潜在治疗方法,可增强左室收缩功能和舒张功能,并具有良好的临床疗效。未来的研究需要对右心室功能进行更广泛的评估和更长的随访。图形摘要:https://www.europeanreview.org/wp/wp-content/uploads/abstract.jpg。
{"title":"Dapagliflozin enhances systolic and diastolic function in concordance with clinical response in patients with left ventricular dysfunction.","authors":"A E Abou Warda, J D Duarte, M Nabil Salem, H F Salem, A N Moharram, A S Alanazi, A I Alzarea, T G Alsahli, H Sultan, M A Alrashdi, A F Altebainawi, B Emil Ibrahim, S Ibrahim Alnahrawi, K Kamel Megalaa, B Zarif, R M Sarhan","doi":"10.26355/eurrev_202505_37222","DOIUrl":"10.26355/eurrev_202505_37222","url":null,"abstract":"<p><p>OBJECTIVE: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have reshaped heart failure (HF) management. However, evidence regarding their effects on cardiac structure, particularly for dapagliflozin, remains inconsistent. This study evaluates dapagliflozin's impact on echocardiographic parameters and its concordance with clinical response. MATERIALS AND METHODS: A prospective, randomized controlled study included HF patients with left ventricular (LV) dysfunction, divided into dapagliflozin-treated and dapagliflozin-naïve groups. Echocardiography and speckle-tracking strain analysis were conducted at baseline and six months. The primary outcome was the change in indexed LV mass. Secondary outcomes included LV function, volumes, dimensions, functional mitral regurgitation, global longitudinal strain (GLS), diastolic function, right ventricular (RV) function, and clinical response assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ) score. RESULTS: Among 240 participants, 160 received dapagliflozin in addition to guideline-directed medical therapy, while 80 were dapagliflozin-naïve. Adjusted regression analysis showed significant improvements in LV mass index (-43.51 g/m², 95% CI: -59.4 to -27.5, p < 0.0001), end-systolic volume (-29.45 mL, 95% CI: -43.9 to -14.9, p < 0.0001), and end-diastolic volume (-29.44 mL, 95% CI: -47.9 to -10.9, p = 0.0021). Improvements were also observed in LV ejection fraction (5.15%, 95% CI: 2.84 to 7.45, p < 0.0001), GLS (-1.99%, 95% CI: -2.87 to -1.11, p < 0.0001), E/A ratio (-0.56, 95% CI: -1.01 to -0.10, p = 0.016), effective regurgitant orifice area (EROA) (-0.18 cm², 95% CI: -0.28 to -0.081, p = 0.0006), tricuspid annular plane systolic excursion (TAPSE) (0.38 cm, 95% CI: 0.15 to 0.62, p = 0.0024), and composite clinical outcome (HR 0.65, 95% CI: 0.43-0.98, p = 0.043). LVEF, GLS, E/A ratio, TAPSE, inferior vena cava diameter, and left atrial area correlated with clinical response. CONCLUSIONS: Dapagliflozin emerges as a potential therapy for patients with left ventricular dysfunction, enhancing LV systolic function and diastolic performance, alongside a favorable clinical response. Future studies with more extensive assessment of right ventricular function and longer follow-up are warranted.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/abstract.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"231-247"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37229
Q-F Xu, Y-X Tang, X Wang
The article "LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients" by Q.-F. Xu, Y.-X. Tang, X. Wang published in Eur Rev Med Pharmacol Sci 2018; 22 (14): 4440-4447-DOI: 10.26355/eurrev_201807_15495-PMID: 30058681 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/4756B8806339A2FA95E3A77A3FB451), the journal has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal's investigation identified a discrepancy between the data described in the text and the content presented in Figure 1, raising concerns about the originality and accuracy of the data. Additionally, detailed information regarding Ethics Approval was missing. The authors have been notified about the ongoing investigation and were asked to provide the original data, however, they have not responded to these communications. As a result, due to unresolved concerns regarding data integrity, lack of ethical approval documentation, and the authors' failure to respond to repeated requests for clarification, the article has been retracted. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/15495.
{"title":"Retraction Note: LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.","authors":"Q-F Xu, Y-X Tang, X Wang","doi":"10.26355/eurrev_202505_37229","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37229","url":null,"abstract":"<p><p>The article \"LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients\" by Q.-F. Xu, Y.-X. Tang, X. Wang published in Eur Rev Med Pharmacol Sci 2018; 22 (14): 4440-4447-DOI: 10.26355/eurrev_201807_15495-PMID: 30058681 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/4756B8806339A2FA95E3A77A3FB451), the journal has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal's investigation identified a discrepancy between the data described in the text and the content presented in Figure 1, raising concerns about the originality and accuracy of the data. Additionally, detailed information regarding Ethics Approval was missing. The authors have been notified about the ongoing investigation and were asked to provide the original data, however, they have not responded to these communications. As a result, due to unresolved concerns regarding data integrity, lack of ethical approval documentation, and the authors' failure to respond to repeated requests for clarification, the article has been retracted. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/15495.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"222"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37227
X-S Bai, G Bai, L-D Tang, Y Li, Y Huan, H Wang
The article "MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway" by X.-S. Bai, G. Bai, L.-D. Tang, Y. Li, Y. Huan, H. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24 (5): 2640-2646-DOI: 10.26355/eurrev_202003_20533-PMID: 32196614 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised by a third party regarding possible overlaps and duplication in Figure 2, the Editor in Chief has started an investigation to assess the validity of the concerns, as well as a possible Figure manipulation. The journal's investigation revealed overlaps between panels "Model" and "miR-195 agomir" and between "Control" and "Model" of Figure 2. The authors have been notified about the ongoing investigation and were asked to provide the original data, however, they have not responded to these communications. Therefore, the manuscript is retracted for figure duplication and manipulation. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20533.
{"title":"Retraction Note: MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway.","authors":"X-S Bai, G Bai, L-D Tang, Y Li, Y Huan, H Wang","doi":"10.26355/eurrev_202505_37227","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37227","url":null,"abstract":"<p><p>The article \"MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway\" by X.-S. Bai, G. Bai, L.-D. Tang, Y. Li, Y. Huan, H. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24 (5): 2640-2646-DOI: 10.26355/eurrev_202003_20533-PMID: 32196614 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised by a third party regarding possible overlaps and duplication in Figure 2, the Editor in Chief has started an investigation to assess the validity of the concerns, as well as a possible Figure manipulation. The journal's investigation revealed overlaps between panels \"Model\" and \"miR-195 agomir\" and between \"Control\" and \"Model\" of Figure 2. The authors have been notified about the ongoing investigation and were asked to provide the original data, however, they have not responded to these communications. Therefore, the manuscript is retracted for figure duplication and manipulation. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20533.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"221"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37225
P I Fiore, S Soares, A Seidel, R Garibaldi
OBJECTIVE: End-stage ankle arthritis is a debilitating condition for which ankle arthrodesis (AA) remains a principal surgical option. Open and arthroscopic techniques are widely used, yet the literature presents heterogeneous findings. This umbrella review consolidates systematic reviews and meta-analyses to compare open vs. arthroscopic ankle arthrodesis in terms of fusion rates, complications, and hospital stay duration. MATERIALS AND METHODS: Following a registered protocol (PROSPERO ID: CRD420246233349), we searched articles on PubMed, Embase, and the Cochrane Library from November 2 to November 10, 2024. We included systematic reviews and meta-analyses in English comparing open and arthroscopic AA, capturing data on fusion rates, postoperative complications (e.g., nonunion, infection), and hospital stay. Quality was assessed with AMSTAR 2. A descriptive synthesis was chosen due to methodological heterogeneity. RESULTS: Eight systematic reviews encompassing 74 primary studies (4,631 total procedures) met the inclusion criteria. Fusion rates were consistently high but higher with arthroscopic techniques (range 88.7-95.1%) compared to open methods (range 78.5-85.0%), with odds ratios frequently around 2.0-3.3 favoring arthroscopy. Complication rates (e.g., infection, wound problems) were significantly lower in arthroscopic groups, typically 6-10% vs. 13-18.5% in open groups, corresponding to odds ratios of approximately 0.47-0.60 in favor of arthroscopy. Additionally, hospital stays were shortened by an average of 1.2-1.8 days with arthroscopic approaches, reflecting a weighted mean difference often exceeding -1.60 days. These findings were attributed mainly to the minimally invasive nature of arthroscopy, which reduces soft tissue disruption and expedites recovery. CONCLUSIONS: Arthroscopic ankle arthrodesis demonstrates superior outcomes over open techniques, offering higher fusion rates, fewer complications, and shorter hospital stays. Although open approaches remain viable, particularly for complex deformities, these data underscore the procedural and systemic advantages of arthroscopy in most clinical scenarios. Further research should aim to refine indications, optimize arthroscopic protocols, and investigate patient-specific factors - such as smoking status and comorbidities - that may influence surgical outcomes.
{"title":"Open vs. arthroscopic ankle arthrodesis: a comprehensive umbrella review of outcomes and complications.","authors":"P I Fiore, S Soares, A Seidel, R Garibaldi","doi":"10.26355/eurrev_202505_37225","DOIUrl":"10.26355/eurrev_202505_37225","url":null,"abstract":"<p><p>OBJECTIVE: End-stage ankle arthritis is a debilitating condition for which ankle arthrodesis (AA) remains a principal surgical option. Open and arthroscopic techniques are widely used, yet the literature presents heterogeneous findings. This umbrella review consolidates systematic reviews and meta-analyses to compare open vs. arthroscopic ankle arthrodesis in terms of fusion rates, complications, and hospital stay duration. MATERIALS AND METHODS: Following a registered protocol (PROSPERO ID: CRD420246233349), we searched articles on PubMed, Embase, and the Cochrane Library from November 2 to November 10, 2024. We included systematic reviews and meta-analyses in English comparing open and arthroscopic AA, capturing data on fusion rates, postoperative complications (e.g., nonunion, infection), and hospital stay. Quality was assessed with AMSTAR 2. A descriptive synthesis was chosen due to methodological heterogeneity. RESULTS: Eight systematic reviews encompassing 74 primary studies (4,631 total procedures) met the inclusion criteria. Fusion rates were consistently high but higher with arthroscopic techniques (range 88.7-95.1%) compared to open methods (range 78.5-85.0%), with odds ratios frequently around 2.0-3.3 favoring arthroscopy. Complication rates (e.g., infection, wound problems) were significantly lower in arthroscopic groups, typically 6-10% vs. 13-18.5% in open groups, corresponding to odds ratios of approximately 0.47-0.60 in favor of arthroscopy. Additionally, hospital stays were shortened by an average of 1.2-1.8 days with arthroscopic approaches, reflecting a weighted mean difference often exceeding -1.60 days. These findings were attributed mainly to the minimally invasive nature of arthroscopy, which reduces soft tissue disruption and expedites recovery. CONCLUSIONS: Arthroscopic ankle arthrodesis demonstrates superior outcomes over open techniques, offering higher fusion rates, fewer complications, and shorter hospital stays. Although open approaches remain viable, particularly for complex deformities, these data underscore the procedural and systemic advantages of arthroscopy in most clinical scenarios. Further research should aim to refine indications, optimize arthroscopic protocols, and investigate patient-specific factors - such as smoking status and comorbidities - that may influence surgical outcomes.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-16.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"268-277"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37223
A Alqadi, E Almodyan, M N Alanazi, S S Alghamdi, M H Ahmed, S Badi, A S Alghamdi
OBJECTIVE: Diabetes Mellitus (DM) is a global concern with a high prevalence among the Saudi population. Uncontrolled diabetes is associated with serious medical complications and an increase in mortality and morbidity. Vitamin D deficiency may have the potential to decrease insulin sensitivity and alter lipid metabolism. This study aimed to assess the impact of vitamin D supplements on glycemic control and lipid profile among individuals living with diabetes in Saudia Arabia. MATERIALS AND METHODS: This retrospective study recruited 254 individuals with diabetes. The medical records were searched for age, gender, HbA1c, fasting blood glucose (FBG), Vitamin D and lipid profiles. The population records were extracted in two intervals: before taking vitamin D supplements and three months after receiving supplements. Paired t-test and confidence intervals were used to compare HbA1c, FBG, vitamin D, and other extracted variables between intervals. Vitamin D levels were compared between genders in each interval. RESULTS: The supplementation of vitamin D leads to improvement in vitamin D from a mean of 45.4 to 65 (normal reference range 50-150). Supplementation of vitamin D showed significant improvement in HbA1c, FBG, all parameters of lipid profile, renal and liver function and hemoglobin (p < 0.001) when t-test was used and confidence interval calculated. CONCLUSIONS: Vitamin D plays a potential role in insulin sensitivity and lipid metabolism. Therefore, maintaining optimal level of vitamin D through its supplements or sun exposure might help to improve heath and decrease complications especially in individuals with diabetes.
{"title":"Vitamin D supplements and effect on glycemic control and lipid profile in individuals living with diabetes: a retrospective study.","authors":"A Alqadi, E Almodyan, M N Alanazi, S S Alghamdi, M H Ahmed, S Badi, A S Alghamdi","doi":"10.26355/eurrev_202505_37223","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37223","url":null,"abstract":"<p><p>OBJECTIVE: Diabetes Mellitus (DM) is a global concern with a high prevalence among the Saudi population. Uncontrolled diabetes is associated with serious medical complications and an increase in mortality and morbidity. Vitamin D deficiency may have the potential to decrease insulin sensitivity and alter lipid metabolism. This study aimed to assess the impact of vitamin D supplements on glycemic control and lipid profile among individuals living with diabetes in Saudia Arabia. MATERIALS AND METHODS: This retrospective study recruited 254 individuals with diabetes. The medical records were searched for age, gender, HbA1c, fasting blood glucose (FBG), Vitamin D and lipid profiles. The population records were extracted in two intervals: before taking vitamin D supplements and three months after receiving supplements. Paired t-test and confidence intervals were used to compare HbA1c, FBG, vitamin D, and other extracted variables between intervals. Vitamin D levels were compared between genders in each interval. RESULTS: The supplementation of vitamin D leads to improvement in vitamin D from a mean of 45.4 to 65 (normal reference range 50-150). Supplementation of vitamin D showed significant improvement in HbA1c, FBG, all parameters of lipid profile, renal and liver function and hemoglobin (p < 0.001) when t-test was used and confidence interval calculated. CONCLUSIONS: Vitamin D plays a potential role in insulin sensitivity and lipid metabolism. Therefore, maintaining optimal level of vitamin D through its supplements or sun exposure might help to improve heath and decrease complications especially in individuals with diabetes.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-NEW.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"248-257"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37224
N Pongsakonpruttikul, C Angthong, V Kittichai, K M Naing, S Chuwongin, P Puengpipattrakul, S Boonsang, T Tongloy
OBJECTIVE: This study aimed to assess the performance of an image retrieval system based on the deep metric learning (DML) approach in discriminating between early and late stages of degenerative intervertebral disc degeneration (IDD). MATERIALS AND METHODS: A total of 2,341 sagittal-plane lumbar spinal MR images were obtained and labeled as early and late degeneration using the Pfirrmann classification. Both the DML model and the Object Detection Model based on a state-of-the-art YOLOv7tiny were trained and tested using the labeled data. Then, performance parameters, such as sensitivity and precision, were computed and compared. RESULTS: The trained DML model achieved both sensitivity and precision levels of approximately 93% and 95%, respectively, and an area under the receiver operating characteristic curve of at least 0.96. The trained Object Detection Model based on modified YOLOv7tiny achieved a precision of 92.6%, a sensitivity of 85.9%, and a mean average precision (mAP) of 0.851. CONCLUSIONS: These results showed that DML yielded a state-of-the-art performance and could be used as a diagnostic tool for discriminating the severity of IDD via MRI.
{"title":"Artificial intelligence assistance using deep metric learning vs. object detection in classifying lumbar disc degeneration on magnetic resonance images.","authors":"N Pongsakonpruttikul, C Angthong, V Kittichai, K M Naing, S Chuwongin, P Puengpipattrakul, S Boonsang, T Tongloy","doi":"10.26355/eurrev_202505_37224","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37224","url":null,"abstract":"<p><p>OBJECTIVE: This study aimed to assess the performance of an image retrieval system based on the deep metric learning (DML) approach in discriminating between early and late stages of degenerative intervertebral disc degeneration (IDD). MATERIALS AND METHODS: A total of 2,341 sagittal-plane lumbar spinal MR images were obtained and labeled as early and late degeneration using the Pfirrmann classification. Both the DML model and the Object Detection Model based on a state-of-the-art YOLOv7tiny were trained and tested using the labeled data. Then, performance parameters, such as sensitivity and precision, were computed and compared. RESULTS: The trained DML model achieved both sensitivity and precision levels of approximately 93% and 95%, respectively, and an area under the receiver operating characteristic curve of at least 0.96. The trained Object Detection Model based on modified YOLOv7tiny achieved a precision of 92.6%, a sensitivity of 85.9%, and a mean average precision (mAP) of 0.851. CONCLUSIONS: These results showed that DML yielded a state-of-the-art performance and could be used as a diagnostic tool for discriminating the severity of IDD via MRI.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-abstract-15.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"258-267"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-01DOI: 10.26355/eurrev_202505_37231
X-H Hu, J Dai, H-L Shang, Z-X Zhao, Y-D Hao
The article "High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma" by X.-H. Hu, J. Dai, H.-L. Shang, Z.-X. Zhao, Y.-D. Hao, published in Eur Rev Med Pharmacol Sci 2018; 22 (22): 7640-7645-DOI: 10.26355/eurrev_201811_16379-PMID: 30536305 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/2F91E52E0FA92A70237B1ECA287AF6), the Editor in Chief has started an investigation to assess the validity of the concerns raised. The journal's investigation identified that authors used primers specific to mouse genes for clinical samples, revealing ethical misconduct and data fabrication. The Editorial Team has contacted the authors to inform them of the ongoing investigation and to request the original data supporting the manuscript; however, the authors have not responded to these communications. Consequently, the Editor in Chief has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16379.
{"title":"Retraction Note: High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.","authors":"X-H Hu, J Dai, H-L Shang, Z-X Zhao, Y-D Hao","doi":"10.26355/eurrev_202505_37231","DOIUrl":"https://doi.org/10.26355/eurrev_202505_37231","url":null,"abstract":"<p><p>The article \"High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma\" by X.-H. Hu, J. Dai, H.-L. Shang, Z.-X. Zhao, Y.-D. Hao, published in Eur Rev Med Pharmacol Sci 2018; 22 (22): 7640-7645-DOI: 10.26355/eurrev_201811_16379-PMID: 30536305 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/2F91E52E0FA92A70237B1ECA287AF6), the Editor in Chief has started an investigation to assess the validity of the concerns raised. The journal's investigation identified that authors used primers specific to mouse genes for clinical samples, revealing ethical misconduct and data fabrication. The Editorial Team has contacted the authors to inform them of the ongoing investigation and to request the original data supporting the manuscript; however, the authors have not responded to these communications. Consequently, the Editor in Chief has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16379.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"223"},"PeriodicalIF":3.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}